Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028.
Saved in:
| Title: | Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028. |
|---|---|
| Authors: | Varga, Andrea1 (AUTHOR) Andrea.VARGA@gustaveroussy.fr, Piha-Paul, Sarina1 (AUTHOR), Ott, Patrick A.1 (AUTHOR), Mehnert, Janice M.1 (AUTHOR), Berton-Rigaud, Dominique1 (AUTHOR), Morosky, Anne1 (AUTHOR), Yang, Ping1 (AUTHOR), Ruman, Jane1 (AUTHOR), Matei, Daniela1 (AUTHOR) |
| Source: | Gynecologic Oncology. Feb2019, Vol. 152 Issue 2, p243-250. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00908258 |
|---|---|
| DOI: | 10.1016/j.ygyno.2018.11.017 |
